TMS Device May Offer Nondrug Option for Migraine Prevention

An FDA-approved device that delivers transcranial single-pulse magnetic stimulation significantly reduces the number of migraine headache days per month, potentially providing a nondrug prevention option.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply